People · Operator
Named in public records as an officer, director or promoter · active 2009–2021 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| IsoPlexis Corp | — | Other Technology | Series C | $127.0M | $2.3B | 2016 |
| Integrated Diagnostics, Inc. | — | Biotechnology | Series B | $45.3M | $242.1M | 2009 |
| Sofie Biosciences, Inc. | — | Biotechnology | Series B | $26.4M | $37.7M | 2013 |
| Indi Molecular, Inc. | — | Biotechnology | Series A | $4.5M | $161.8M | 2017 |
| Cloverly Inc. | — | Other Technology | Seed | $2.1M | $44.7M | 2021 |
James Heath at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Heath on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Leroy Hood | 2 | 5 |
| Albert Luderer | 2 | 2 |
| Daniel Wagner | 1 | 13 |
| Arnold Oronsky | 1 | 10 |
| Michael Liang | 1 | 9 |
| Stephen Davis | 1 | 8 |
| David Barker | 1 | 7 |
| K. Leonard Judson | 1 | 7 |
| John Conley | 1 | 5 |
| Gregory Ho | 1 | 4 |
| Vasant Kamath | 1 | 4 |
| Sharon Kedar | 1 | 3 |
| Michael Egholm | 1 | 3 |
| Roy Doumani | 1 | 3 |
| John Bencich | 1 | 3 |
| Jay Moyes | 1 | 2 |
| Ajit E. Singh | 1 | 2 |
| Johannes Czernin | 1 | 2 |
| Sean Mackay | 1 | 2 |
| Carl W. McKinzie | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.